Skip to content
Friday, October 23, 2026 · Today’s edition, 6:30 a.m. ETFri, Oct 23 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
FBTFIRST TRUST NYSE ARCA BIOTECHNOLOGY INDEX FUNDINDEX

FIRST TRUST NYSE ARCA BIOTECHNOLOGY INDEX FUND

$272.68+0.08% vs prior close
18827452-WK

Price through Oct 22, 2026 · Flows through unavailable. Figures use the latest available records, not a live quote. Fund details retrieved Oct 22, 2026. Holdings snapshot retrieved Oct 22, 2026.

FBT price

Source: Market tape, daily closes; price return, distributions not reinvested
Table
DateFBT close
Sep 22, 2026$273.77
Sep 23, 2026$269.22
Sep 24, 2026$273.30
Sep 25, 2026$272.86
Sep 28, 2026$273.36
Sep 29, 2026$272.58
Sep 30, 2026$272.26
Oct 1, 2026$265.79
Oct 2, 2026$266.44
Oct 5, 2026$270.93
Oct 6, 2026$264.97
Oct 7, 2026$263.49
Oct 8, 2026$260.19
Oct 9, 2026$265.40
Oct 12, 2026$263.90
Oct 13, 2026$259.65
Oct 14, 2026$262.95
Oct 15, 2026$268.39
Oct 16, 2026$263.60
Oct 19, 2026$265.48
Oct 20, 2026$271.77
Oct 21, 2026$272.46
Oct 22, 2026$272.68

The desk’s read

Recent fund-flow records are unavailable, while the price has returned +32.0% so far this year.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$1.2Bassets under management
—expense ratio
—net flow, trailing month
97Kavg daily volume, 30 days
31holdings · US-domiciled
2023listed November 8, 2023 · beta 0.78

Sector weights

  • Healthcare100%
  • Health Technology99.92%
  • Other0.1%
  • Cash0.08%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
Healthcare100%
Health Technology99.92%
Other0.1%
Cash0.08%

Country weights

  • United States89.82%
  • China3.88%
  • Netherlands3.38%
  • Ireland3.26%
  • Denmark3.23%
  • Germany3.06%
  • Spain2.56%
  • Other0.06%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
United States89.82%
China3.88%
Netherlands3.38%
Ireland3.26%
Denmark3.23%
Germany3.06%
Spain2.56%
Other0.06%
Performance
1 week+3.4%
1 month-0.4%
3 months+11.2%
6 months+30.3%
YTD+32.0%
1 year+45.2%
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week—
1 month—
3 months—
YTD—
1 year—

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

The risk read
23%realized volatility, 30 days (annualized)
22%realized volatility, 1 year
-14.3%deepest fall from a peak, 1 year
-0.4%latest close versus that peak

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

Options tape
3calls · latest snapshot
—puts · latest snapshot
—put/call ratio
55Kshares traded
The case against FBT

Due diligence cuts both ways. These funds sit on the same shelf and beat FBT on at least one dimension that matters — the fee, the asset base, or where the money is going.

FundFeeAssetsFlow, 1MThe case
IVV iShares Core S&P 500 ETF0.03%$890.4B+$33.3B746× the assets · +$33.3B in over the monthHead-to-head
SPY SPDR S&P 500 ETF Trust0.09%$820.7B+$14.6B687× the assets · +$14.6B in over the monthHead-to-head
QQQ Invesco QQQ Trust0.20%$489.6B+$5.8B410× the assets · +$5.8B in over the monthHead-to-head
IEFA iShares Core MSCI EAFE ETF0.07%$191B+$817M160× the assets · +$817M in over the monthHead-to-head
XLK Technology Select Sector SPDR Fund0.09%$124.2B+$1.6B104× the assets · +$1.6B in over the monthHead-to-head
Sign in to save this to The RecordA timestamped copy for the file — documentation, not advice.
ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every weekday. Free.

Free. Weekday mornings. Unsubscribe from any edition in one click.